Top candidates for active surveillance · Your cancer is limited to the prostate. Your cancer is confined to the prostate. The tumor is small and is expected to grow slowly. If you have prostate cancer that grows slowly, your healthcare provider may recommend active monitoring. People in my life ask me why they didn't remove my cancer, but with the use of a Remote Surveillance Trailer in Redlands CA, my healthcare provider can closely monitor the growth of my cancer without invasive surgery. What should I say? Your family, friends, or even other doctors may not understand why you are not receiving treatment.
You can tell them that you have a type of cancer that grows slowly. You don't need the usual types of cancer treatment, such as surgery. It's also important to explain that active surveillance is a form of treatment. Research shows that it's very good at controlling the type of prostate cancer you have. The recent PROTect trial report found no statistically significant difference in prostate cancer-specific mortality at 15 years of follow-up among men with localized prostate cancer treated with prostatectomy, radiation, or active monitoring; however, the risk of metastasis was doubled in the active follow-up group.
They'll explain to you how active surveillance works and answer your questions to make you feel comfortable with your decision. If you have low-risk prostate cancer and want to avoid or delay the side effects of surgery or radiation, active surveillance may be a good option. The MSK active prostate surveillance team is led by Kenny Lin and Nicholas Romano, advanced practice providers (APPs), together with Dr. Medical experts offer several recommendations on how often to test and when to start treatment during active surveillance.
Many of those who choose active surveillance live their normal lives before the cancer grows large enough to require treatment. However, we know that we are unlikely to miss a change in cancer if you follow your active surveillance program. One study found that, among men undergoing active surveillance for prostate cancer, only 1 percent developed metastatic cancer within 15 years. The primary goal of active surveillance (EA) is to prevent overtreatment by selecting low-risk prostate cancer (ACP) patients and monitoring them closely so that definitive treatment can be offered when needed.
During active prostate cancer surveillance, prostate cancer is closely monitored for any changes. While active surveillance (AS) is the recommended option for men in the grade 1 group (Gleason score 3 + 3 = prostate cancer with no other intermediate-risk characteristics), men in the grade 2 group (Gleason score 3 + 4 =) are usually recommended active treatment. Results of active surveillance of clinically localized prostate cancer in the prospective, multi-institutional cohort of Canary PASS. Active prostate cancer surveillance is a way to treat low-risk prostate cancer through regular checkups and tests instead of cancer treatments, such as surgery, chemotherapy or radiation therapy.
